Coverage
-
May 29, 2019
Pomerantz LLP has asked a California federal judge to approve over $2.9 million in attorney fees for leading Thoratec Corp. shareholders to an $11.9 million deal with the medical equipment company to resolve class action claims it hid risks related to its implantable heart devices.
4 other articles on this case.
View all »